177Lu-PNT2002: Clinical Trials

4 trials of 177Lu-PNT2002, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 terminated, 1 withdrawn. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Active not recruiting 1, Completed 1, Terminated 1, Withdrawn 1
Phase 12Completed 1, Withdrawn 1

Follow 177Lu-PNT2002: new trials by email Literature Review of 177Lu-PNT2002 trials Research Report on 177Lu-PNT2002

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PSMA Therapy and Immunotherapy in Kidney Cancer
Pembrolizumab, 177Lu-PNT2002, (F-18)-DCFPyL - Metastatic Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
Phase 1 / Phase 2WithdrawnSidney Kimmel Comprehensive Cancer Center at Johns Hopkins2025-10-012025-08-19
177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma
177Lu-PNT2002 - Adenoid Cystic Carcinoma
Phase 2TerminatedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins12025-02-102026-01-22
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study
Lutetium Lu-177 PNT2002, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy - Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma
Phase 2Active not recruitingJonsson Comprehensive Cancer Center932022-09-022026-05-26
Radioligand fOr locAl raDiorecurrent proStaTe cancER
177Lu-PNT2002, High Dose Radiation - Prostate Cancer
Phase 1 / Phase 2CompletedGlenn Bauman32022-03-172025-09-12

Conditions studied

Prostatic Neoplasms (2)  ·  Carcinoma, Adenoid Cystic (1)  ·  Carcinoma, Renal Cell (1)  ·  Clear-cell metastatic renal cell carcinoma (1)  ·  Kidney Neoplasms (1)

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)  ·  Glenn Bauman (1)  ·  Jonsson Comprehensive Cancer Center (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Amar Kishan, MD (1)  ·  Ana Kiess, MD, PhD (1)  ·  Glenn Bauman, MD (1)  ·  Yasser Ged, MD (1)

Results publications

PMID 37081426, PMID 41223345